miglustat

Poland

Drugs containing this active substance

  • MIGLUSTAT ACCORD

    The medicine is used in adults for the treatment of mild to moderate Gaucher disease type I (when enzyme replacement therapy is not possible) and in adults and children for the treatment of progressive neurological symptoms in Niemann-Pick disease type C.

    Form: capsules, hard

    Active substance Dosage
    miglustat 100 mg

    ATC: A16AX06

    Manufacturer: G.L. Pharma GmbH